Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.50 USD
Change Today 0.00 / 0.00%
Volume 18.5K
ORGS On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

orgenesis inc (ORGS) Snapshot

Open
$0.47
Previous Close
$0.50
Day High
$0.50
Day Low
$0.43
52 Week High
08/28/14 - $1.00
52 Week Low
01/13/15 - $0.38
Market Cap
49.2M
Average Volume 10 Days
12.2K
EPS TTM
--
Shares Outstanding
98.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ORGENESIS INC (ORGS)

Related News

No related news articles were found.

orgenesis inc (ORGS) Related Businessweek News

No Related Businessweek News Found

orgenesis inc (ORGS) Details

Orgenesis Inc., a development stage company, is engaged in research and development in the biotechnology field in Israel. It intends to develop a technology for regeneration of functional insulin-producing cells thus enabling normal glucose regulated insulin secretion through cell therapy. The company was formerly known as Business Outsourcing Services, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was founded in 2008 and is based in White Plains, New York.

1 Employees
Last Reported Date: 02/19/15
Founded in 2008

orgenesis inc (ORGS) Top Compensated Officers

Chairperson, Chief Executive Officer, Preside...
Total Annual Compensation: $185.6K
Founder and Chief Scientific Officer
Total Annual Compensation: $286.2K
Chief Financial Officer, Treasurer and Secret...
Total Annual Compensation: $6.0K
Chief Executive Officer of Orgenesis Maryland...
Total Annual Compensation: $104.2K
Compensation as of Fiscal Year 2014.

orgenesis inc (ORGS) Key Developments

Orgenesis Inc. Presents at 3rd Global Life Sciences Conference, Jun-11-2015

Orgenesis Inc. Presents at 3rd Global Life Sciences Conference, Jun-11-2015 . Venue: Warsaw Stock Exchange, Warsaw, Poland.

Orgenesis Inc. Appoints Chris Buyse as a Board of Directors

Orgenesis Inc. appointed Chris Buyse as a board of directors. Mr. Prior to that, from 2006 to 2014, Mr. Buyse was Chief Financial Officer and Director of ThromboGenics NV. Before joining ThromboGenics, he was Chief Financial Officer of CropDesign, where he coordinated its acquisition by BASF in July 2006. Prior to joining CropDesign, Mr. Buyse served as finance manager at WorldCom/MCI Belux, and Chief Financial Officer and interim Chief Executive Officer of Keyware Technologies. In addition, Mr. Buyse has held various positions in finance at Spector Photo Group, Suez Lyonnaise des Eaux and Unilever. Chris Buyse is also currently a director in several private and public companies, such as Bone Therapeutics SA, Cardio 3 Biosciences SA, Iteos, SA and Bioxodes SA.

Orgenesis Inc. Appoints Hugues Bultot to its Board of Directors

Orgenesis Inc. announced the appointment of Hugues Bultot to its board of directors. Since April 2014, Bultot has been the Chief Executive Officer of MaSTherCell SA. Bultot is also the Founder and CEO of Univercells SA.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ORGS:US $0.50 USD 0.00

ORGS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ORGS.
View Industry Companies
 

Industry Analysis

ORGS

Industry Average

Valuation ORGS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORGENESIS INC, please visit www.orgenesis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.